patented technology to grow and expand adult Stem Cells

Adult stem cell development company commencing clinical trials applicable to estimated $30 billion degenerative disease market place

Free
Message: from CH Bird at Segue:interview Dr. Ayoub conducted with PLRS Dr. Prather

as for risks, lol..all penny stocks are risky, but the ones with patents have the best potential..Frank Carlucci evidently agrees with me..he owns 4.1% of this company and I do not think he agrees with you

if in doubt? don't! do your own DD ..I did mine, I have a ton of PLRS and plan on accumulating more

Share
New Message
Please login to post a reply